×







We sell 100% Genuine & New Books only!

Diabetic Retinopathy : Current Pharmacologic Treatment And Emerging Strategies at Meripustak

Diabetic Retinopathy : Current Pharmacologic Treatment And Emerging Strategies by Michael W Stewart, Springer International Publishing

Books from same Author: Michael W Stewart

Books from same Publisher: Springer International Publishing

Related Category: Author List / Publisher List


  • Price: ₹ 11315.00/- [ 25.50% off ]

    Seller Price: ₹ 8429.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Michael W Stewart
    PublisherSpringer International Publishing
    ISBN9789811035081
    Pages268
    BindingHardbound
    LanguageEnglish
    Publish YearApril 2017

    Description

    Springer International Publishing Diabetic Retinopathy : Current Pharmacologic Treatment And Emerging Strategies by Michael W Stewart

    A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option.Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.



    Book Successfully Added To Your Cart